CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

Right arrow Help viewing high resolution images
Right arrow Return to article


Fig. 6. Role of IGF-IR in the sensitization of MCF-7 and T-47D cells to PD098059. A, MCF-7 and T-47D cells were plated in triplicate in 24-well plates at densities of 1 x 104 and 2.5 x 104 cells/cm2, respectively. Cells subsequently were incubated in complete growth medium supplemented with control antibody/DMSO, control antibody/PD098059, anti-IGF-IR antibody/DMSO, or anti-IGF-IR antibody/PD098059. After 4 days, triplicate wells were counted for each treatment (Table 1) . The number of cells in antibody/PD098059-treated wells was expressed as a percentage of the number of cells in the respective antibody/DMSO-treated wells. Means are shown; bars, SD. The Student’s paired t test was used to determine that PD098059-inhibited growth in the presence of anti-IGF-IR blocking antibody was significantly different from PD098059-inhibited growth with control IgG antibody. *, P < 0.05. Data shown are representative of three similar experiments. B, MCF-7 and T-47D cells were plated at equivalent subconfluent densities and were treated as in A or were left untreated. After 3 h, cell lysates were prepared with RIPA buffer, and 750 µg of lysate protein were immunoprecipitated (IP) with polyclonal anti-IGF-IR, resolved by SDS-PAGE, and immunoblotted with anti-phosphotyrosine (anti-pTyr). From the same lysates, 20 µg of protein were fractionated by SDS-PAGE and immunoblotted with anti-phosphoERK1/ERK2. The membranes were stripped and reprobed with anti-IGF-IR or anti-ERK2 to confirm that equivalent amounts of protein were present in each lane.





Right arrow Return to article


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation